Prevalence of antibody reacting with neuronal cytoplasm was 3% in 60 normal controls and 6% among a wide variety of patients with diverse neurological disorders. However, one-third of 33 patients with Parkinson's disease showed presence of antineuronal antibody. Among patients with HD, a significant association was noted between duration of clinical disease greater than 7 yr and titers of antibody of 1:2 or greater (P < 0.001).
INTRODUCTION
Huntington's disease (HD)' is a degenerative disease of the central nervous system which appears to be related to autosomal dominant genetic inheritance (1) (2) (3) (4) (5) . Numerous family studies have documented the genetic distribution of this disorder, however precise insight into its etiology is not yet available. Some evidence has been accumulated relating abnormalities in central nervous system receptor mechanisms involving reduced glutamic acid decarboxylase activity or gamma aminobutyric acid (6, 7) receptors to HD, but as yet no clear idea of genesis has been presented. The present study arose from a chance observation that several sera from patients with HD contained antibodies to neuronal cytoplasmic structures which were particularly prominent in human caudate nucleus. During the course of previous work, it was found that a substantial proportion of sera from children with Sydenham's chorea showed anticaudate nucleus neuronal antibody (8, 9) . In the case of these sera from children with rheumatic fever, antibody activity could be completely absorbed using purified membranes from hemolytic group A streptococci. A large number of controls, including some patients with diverse neurological diseases, was also previously studied, and no significant increase in antineuronal antibodies was recorded (9) . Subsequently, several sera from patients with HD were also studied and these sera showed striking staining of neurons in frozen sections of human caudate nucleus when indirect immunofluorescence technique was used. Antibody activity from sera of HD patients was not removed by streptococcal membrane absorption and it appeared that this reaction was Bemalillo County Medical Center were some of the subjects studied. An additional nine affected individuals were studied through samples kindly provided by their responsible physicians throughout the country. 25 HD subjects were studied from clinical material available at Ann Arbor, Mich. and another 17 patients were drawn from patients followed through the Neurology service at the University of Colorado Medical Center. Finally, 11 HD subjects from Norway were also included in afflicted propositi studied. Duration of overt disease was estimated from the date of first recorded clinical symptoms and ranged from 1 to 28 yr. 115 blood samples from members of 31 families of HD patients were also studied. First-degree relatives were defined as parents, children, and siblings of probands with HD whereas second-degree relatives were twice removed from the proband (i.e., grandparents, uncles, aunts, cousins, nieces, and nephews). An attempt was made to study as many living relatives, both blood related and nonblood related, as were available. In addition, whenever possible, particular care was used to study spouses of patients afflicted with HD. In all, a total of 20 spouses were included in this phase of the study.
In one HD patient, simultaneous serum and cerebrospinal fluid samples were available. Spinal fluid was concentrated 50 times to obtain an IgG concentration similar to that of the serum (11.0 mg/ml).
Control sera were drawn from a group of normal subjects and patients with diverse medical conditions as previously noted (9) . An additional new group of 198 neurological controls was included in the present study. These were obtained from the in-patient and out-patient neurology services of the Bemalillo County Medical Center, Albuquerque Veterans Administration Hospital, and St. Josephs Hospital, Albuquerque, N. Mex. Sera were obtained from patients with a wide variety of neurological diseases including Parkinson's disease, senile dementia, transverse myelitis, strokes, brain and spinal cord tumors, central nervous system trauma, multiple sclerosis, and miscellaneous neurological conditions. A summary of the types of patients included among the neurological controls is shown in Table I .
Assay systems. The primary study technique utilized indirect immunofluorescence and unfixed frozen sections of normal adult human brain as previously described (8, 9) . Brain was obtained from the medical examiner's office from individuals who had sustained accidental death and was studied within [4] [5] [6] [7] [8] [9] [10] [11] [12] nervous system tissues may be due to Fc binding of IgG to myelin components. Accordingly, IgG from positive sera was isolated by ammonium sulfate precipitation or DEAE ion-exchange chromatography and pepsin digested to produce F(ab')2 fragments as previously described (9) . Specificity of IgG binding to central nervous system structures was thus studied by comparing immunofluorescence with whole serum or isolated IgG and F(ab')2 fragments of the same IgG.
To examine the ability of the antineuronal antibodies to bind complement, sections were incubated with positive sera and washed as described, thereafter overlaid with fresh normal human serum as a source of complement, washed, and finally treated with fluorescein isothiocyanate-labeled antihuman C3. As a control, the normal human serum was heat inactivated at 56°C for 30 min before use.
A search for specificity of antineuronal fluorescent staining was made using various types of enzymatic and clinical treatments of frozen sections with modifications of 9~~~~~~~~~~~~~~~~~.. . .
several methods previously described (12) (13) (14) (15) (16) . These preparations were also used for absorption studies (9) . Lyophilized proteins extracted from whole caudate nucleus with perchloroacetic acid using the method previously described by Wedege (17) were also used for absorption of six selected sera at a concentration of 10 mg/ml.
In some instances sera from HD patients showing strong immunofluorescent staining of human caudate nuclear neuronal cytoplasm were tested for possible specificity for group A streptococcal antigens utilizing group A membranes, cell walls, and carbohydrate kindly provided by Doctors I. van (10, 18, 19) . In these assays the sera were screened undiluted.
RESULTS
HD subjects. 37 of the 80 sera (46.3%) from HD subjects studied showed positive staining reactions for neuronal cytoplasmic fluorescence (Table I, Fig.  1 ). The titers of positive sera are shown in Table II Table III. Almost identical immunofluorescent findings were observed when corresponding brain samples from rats were used instead of human material providing evidence that the antineuronal antibodies were not species specific. Concomitant screening of test sera for the presence of antinuclear antibody as well as mitochondrial and microsomal antibodies was performed to insure neuronal cytoplasmic specificity of the immunofluorescent staining. Five of the positive sera from HD patients showed antinuclear reactivity. However, in these five sera, immunofluorescent staining was also localized to neuronal cytoplasmic structures clearly identified by the concomitant finding ofautofluorescent granules of lipofuscin known to be present in the cyto-1: 16 r * 0 plasm of such cells (Fig. 1) . None of the sera was shown to contain antimitochondrial or antimicrosomal reactivity when tested on rat and human kidney sections.
An attempt was next made to examine whether the presence of positive reactions for antineuronal antibody correlated in any way with clinical duration of disease. Two patients included as presumptive HD had not as yet manifested clinical symptoms but had one parent and one child already involved with overt HD. These subjects (both negative for antineuronal antibody) were not included in this analysis. In 74 patients, where accurate clinical data were available about actual initial onset of disease, it appeared that a larger proportion of patients with duration of disease greater than 7 yr (21/36) showed positive antibody reactions than did subjects with disease duration of 7 yr or less (16/38) (chi-square, 2.82). However, some exceptions to these data were observed. These data are shown graphically in Fig. 2 . It can be seen that sera showing higher titers of antineuronal antibody were more prominent in patients with disease duration of over 7 yr. If patients with titer of antibody of 1:2 or greater in subjects with less than 7 yr of clinical disease were compared to those with 7 yr duration or greater, chi-square was 9.06 (P < 0.001).
In one patient where both serum and spinal fluid were available, concentrated spinal fluid showed only a weak (±) and immunofluorescence reaction whereas serum produced stronger staining (2+) and was positive to a dilution of 1:16.
A diverse group ofcontrol patients was also examined . . HD family studies. 115 sera from 31 families containing at least one HD proband were studied for presence of antineuronal antibody. These sera included 20 husband-wife spouse pairs in which one (husband or wife) had established HD. 6 of 20 unaffected spouses (30%) of subjects with HD showed presence of positive reactions for antineuronal antibody. One spouse showed a titer of 1:16 which was among the highest recorded. Her HD-affected husband was also positive with 1:4 titer. In addition, 13 of 56 first-degree HD family members (23.2%) clearly at risk for eventual development of HD (children of marriages where one parent had established HD) showed presence of antineuronal antibody. By contrast, only 10 .5% or 2 of 19 nonblood-related relatives where such family members were married to spouses at risk for HD were positive for antineuronal antibody. In addition, 19 second-degree relatives indirectly at risk for HD (grandparents with HD) showed a 10.5% incidence ofantibody. Analysis ofthese data by the chisquare method showed a highly significant difference between spouses and first degree relatives directly at risk and normal controls (P < 0.001), Table IV . Illustrative examples of representative family distribution of antineuronal antibody are shown in Fig. 3 .
Attempts to characterize HD serum-staining anti- gen. Frozen tissue sections were treated with DNAase and RNAase and examined with a panel of strongly positive sera. DNAase digestion of sections produced no change in staining, however slight diminution was recorded after RNAase digestion in several instances. Trypsin digestion was also associated with diminution in positive staining of neuronal cytoplasm. No significant changes in staining patterns were noted after lipase, VCN, or EDTA after lipase, neuraminidase, or EDTA treatment. Some increase in immunofluorescent staining occurred after periodate treatment; however this appeared to be nonspecific since parallel control observations using previously negative normal sera also showed an increased general tendency for binding to periodate-treated sections. Similar results using this reagent have been previously recorded (12) . Studies of specificity. 31 of the 37 HD sera positive for antineuronal antibodies were also tested using flourescein isothiocyanate-labeled rabbit antibodies specific for IgG, IgM, and IgA, respectively. In all cases only antineuronal antibodies of the IgG class were detected.
Binding of HD IgG antibody to neuronal tissues was assessed before and after IgG digestion by pepsin. Serum and isolated IgG from positive sera were studied in parallel with pepsin F(ab')2 fragments of IgG in immunofluorescence reactions. Clear evidence ofantibody combining-site binding using F(ab')2 fragments as well as whole IgG preparations was obtained in all positive sera tested (Table V) .
In addition, careful absorption of HD sera with group A streptococcal cell walls, membranes, and purified carbohydrate, utilizing methods previously described (9), produced no diminution or significant Antineuronal Antibodies in Huntington's Chorea (0) (21, 22) . In both, damage to neurons and subsequent alteration of native autologous neuronal antigens might be capable of inducing synthesis of antibodies directed against damaged neuronal structures. The increased titer and prevalence with duration of disease in HD might indeed fit with such an hypothesis. However, it is conceivable that antineuronal antibody in both conditions might be directed against virally induced antigens somehow associated with expression of the disease. Postinfluenzal Parkinsonism has in the past been attributed to long-term viral sequelae and it still remains a possibility in terms of the etiology of the whole disease spectrum itself (23, 24) .
The species nonspecific nature of the antineuronal antibodies provides interesting possibilities for the development of an experimental model of HD in animals, however it is difficult to understand how the antibody during life could directly react with cytoplasmic antigen localized within individual neurons.
The demonstrated ability of the antineuronal antibodies to fix complement, along with binding of pepsin F(ab')2 antibody fragments, provides further support for the antibody nature of this reaction. Whether or not this is involved directly in pathogenesis or in the tissue lesions themselves must await direct The family studies recorded here provide fascinating preliminary data which appear to link an environmental influence or conceivably an infectious agent to the expression of HD. Most telling in this regard were the studies of the 20 spouse pairs where 30% of unaffected spouses showed presence ofantineuronal antibody. First-degree relatives directly at risk showed a prevalence of 23% as against the prevalence of 3% in normal controls. As degree of direct relation to HD parent or grandparents declined, the prevalence of positive antineuronal antibody fell to 10.5%. Since HD has been previously clearly shown to be related to an autosomal dominant inheritance pattern, these data considered together suggest that antineuronal antibody may reflect exposure to some agent or common environmental factor. Such exposure, if it were a virus or slow viral infection (28, 29) , might be magnified in spouses of afflicted patients. However, to actually develop clinical manifestations and progression of the disease, one would theoretically have to possess a specific HD-reactive IR gene (30, 31) . Such a hypothesis might explain the findings recorded in the current report. Additional studies are now needed to attempt to characterize the antigen reactive with HD antineuronal antibody and to further explore the prevalence of such antibody in kindreds as well as spouses of patients with Parkinson's disease.
